IPP Bureau
Roche appoints Wafaa Mamilli as Chief Digital Technology Officer
By IPP Bureau - January 30, 2025
Mamilli last held the role of Chief Digital & Technology Officer and Group President for China, Brazil and Precision Animal Health at Zoetis
Enhertu approved in US for breast cancer post more endocrine therapies
By IPP Bureau - January 30, 2025
Based on DESTINY-Breast06 Phase III trial results which showed Enhertu demonstrated superiority vs. chemotherapy with a median progression-free survival of more than one year
Zota Health Care expands Davaindia Network to 1,413 operational stores
By IPP Bureau - January 29, 2025
The company remains focused on strengthening its direct retail presence and expanding its reach to more customers across India.
OneSource receives EIR with VAI classification from USFDA for BLD facility
By IPP Bureau - January 29, 2025
OneSource operates five cGMP facilities and has a strong track record, with 138 successful regulatory and customer audits to date by all major regulatory bodies
Syensqo partners with MezLight to launch the world’s first sterile reusable surgical task light
By IPP Bureau - January 29, 2025
Novel illumination system with key components molded in Radel® PPSU for durability and repeated sterilization
Supriya Lifescience posts Q3 FY25 PAT up at Rs. 46.78 Cr
By IPP Bureau - January 28, 2025
The 33% year-over-year revenue growth and a remarkable 45% surge in gross profit reflect our strong market presence and efficient execution across therapeutic segments
Torrent Pharmaceuticals posts Q3 FY25 consolidated PAT at Rs. 503 Cr
By IPP Bureau - January 28, 2025
Torrent Pharmaceuticals has reported total income of Rs. 2,842 crores during the period ended December 31, 2024
RPG Life Sciences posts Q3 FY25 PAT higher at Rs. 34.93 Cr
By IPP Bureau - January 28, 2025
RPG Life Sciences has reported total income of Rs. 176.02 crore during the period ended December 31, 2024
Laurus Labs posts Q3 FY25 consolidated PAT higher at Rs. 92.30 Cr
By IPP Bureau - January 28, 2025
Laurus Labs has reported total income of Rs. 1,424.47 crores during the period ended December 31, 2024
Mankind Pharma launches 45-day healthcare mission at Mahakumbh
By IPP Bureau - January 28, 2025
The camp, operational daily from 12 PM to 4 PM, offers free health check-ups, blood pressure monitoring
Toray develops membrane doubling filtration for biopharmaceutical manufacturing processes
By IPP Bureau - January 28, 2025
The company will initially supply prototypes to diverse customers to evaluate in purification processes for producing gene therapy drugs with a view to swift commercialization
Granules India Q3 FY25 PAT drops 6% to Rs 118 Cr
By IPP Bureau - January 27, 2025
The company said it voluntarily paused production at the Gagillapur plant in September 2024 for risk assessment on account of the USFDA observations
Pfizer’s BRAFTOVI combination demonstrates improved response for mutant metastatic colorectal cancer
By IPP Bureau - January 27, 2025
BRAFTOVI combination regimen is the first and only targeted therapy approvedby the U.S. FDA for treatment-naïve patients with metastatic colorectal cancer with a BRAF V600E mutation
SaponiQx, Probius, and Ginkgo Bioworks to revolutionize vaccine adjuvant development
By IPP Bureau - January 27, 2025
Groundbreaking collaboration harnesses AI-driven insights and advanced manufacturing to create next-generation adjuvants for emerging biological threats
AstraZeneca plans US$ 570 million investment in Canada
By IPP Bureau - January 27, 2025
700 new scientific and high-skilled jobs to be created in Greater Toronto Area, investing to execute more than 210 AstraZeneca global clinical studies
